Boothbay Fund Management’s NRX Pharmaceuticals, Inc. Warrant NRXPW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-34,063
| Closed | -$365K | – | 1215 |
|
|
2020
Q3 | $365K | Sell |
34,063
-100
| -0.3% | -$1.07K | 0.02% | 650 |
|
|
2020
Q2 | $359K | Hold |
34,163
| – | – | 0.02% | 553 |
|
|
2020
Q1 | $368K | Hold |
34,163
| – | – | 0.03% | 438 |
|
|
2019
Q4 | $362K | Hold |
34,163
| – | – | 0.03% | 483 |
|
|
2019
Q3 | $361K | Hold |
34,163
| – | – | 0.03% | 446 |
|
|
2019
Q2 | $360K | Hold |
34,163
| – | – | 0.03% | 409 |
|
|
2019
Q1 | $353K | Hold |
34,163
| – | – | 0.03% | 376 |
|
|
2018
Q4 | $13K | Hold |
34,163
| – | – | ﹤0.01% | 544 |
|
|
2018
Q3 | $342K | Hold |
34,163
| – | – | 0.03% | 363 |
|
|
2018
Q2 | $339K | Hold |
34,163
| – | – | 0.03% | 333 |
|
|
2018
Q1 | $334K | Hold |
34,163
| – | – | 0.04% | 334 |
|
|
2017
Q4 | $331K | Buy |
+34,163
| New | +$331K | 0.05% | 335 |
|